Upcoming Clinical Trials:
Please read each description and if you feel you qualify, give our office a call as soon as possible for consult. Candidates meeting criteria will be eligible to participate in study. Compensation and/or treatment may be available and will be free of charge for those selected to participate in trial.
Title: Diabetes Study - A phase 3b, Randomized, Active Comparator, Open-label, Multicenter Study to Compare the Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and to Glimepiride as Add-on Therapy to Metformin in Patients with Type 2 Diabetes.
-Male or Female patients 18 to 80 years old
-Diagnosis of Diabetes Type 2
-Women cannot be pregnant, breast feeding or plan on becoming pregnant during the study.
Serving The Atlanta Community for over 15 years
315 Boulevard NE Suite 300 Atlanta, GA 30312 | 678-705-2355